High Medication Adherence During Periconception Periods Among HIV-1–Uninfected Women Participating in a Clinical Trial of Antiretroviral Pre-exposure Prophylaxis

INTRODUCTION: Pre-exposure prophylaxis (PrEP) may be an important safer conception strategy for HIV-1–uninfected women with HIV-1–infected partners. Understanding medication adherence in this population may inform whether PrEP is a feasible safer conception strategy. METHODS: We evaluated predictors...

Descripción completa

Detalles Bibliográficos
Autores principales: Matthews, Lynn T., Heffron, Renee, Mugo, Nelly R., Cohen, Craig R., Hendrix, Craig W., Celum, Connie, Bangsberg, David R., Baeten, Jared M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JAIDS Journal of Acquired Immune Deficiency Syndromes 2014
Materias:
Epidemiology and Prevention
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4149628/
https://www.ncbi.nlm.nih.gov/pubmed/25118795
http://dx.doi.org/10.1097/QAI.0000000000000246

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4149628/
https://www.ncbi.nlm.nih.gov/pubmed/25118795
http://dx.doi.org/10.1097/QAI.0000000000000246

Ejemplares similares